Holocene Advisors
GH icon

Holocene Advisors’s Guardant Health GH Stock Holding History

Holocene Advisors’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-693,200
Closed -$18.9M – 778
2022
Q4 		$18.9M Hold
693,200
– – 0.12% 187
2022
Q3 		$37.3M Buy
+693,200
New +$35.6M 0.24% 124

Other funds holding GH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CCM
Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Holocene Advisors's GH Position: Q3 2024 in Review

Holocene Advisors sold out of Guardant Health (GH) in Q3 2024, closing a stake of 102,944 shares — an estimated $2.97M sold.

Holocene Advisors first reported a position in GH in Q3 2021 and held it in 11 quarters. The position peaked at $69.7M in Q3 2022. 271 funds tracked by Wall St. Rank hold GH as of Q3 2024.

  • Holocene Advisors reported no remaining Guardant Health position as of Q3 2024 after selling out during the quarter.
  • Holocene Advisors sold 102,944 Guardant Health shares in Q3 2024, an estimated $2.97M.
  • Holocene Advisors first reported a position in Guardant Health in Q3 2021 and held it in 11 quarters.
  • Holocene Advisors's Guardant Health position peaked at $69.7M in Q3 2022.
  • 271 funds tracked by Wall St. Rank held Guardant Health as of Q3 2024.

Based on Holocene Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.